InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,859.85
(
0.77%
)
US TECH 100
19,890.40
(
-0.05%
)
Dow Jones
43,065.22
(
0.47%
)
Brent Oil
74.25
(
-0.89%
)
Bitcoin
65,592.05
(
-0.70%
)
Post# of 26138
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

re-actor

Send PM Follow Ignore
Followers 35
Posts 1986
Boards Moderated 0
Alias Born 12/10/2011

re-actor

Re: Rustler post# 10844

Wednesday, 02/15/2012 12:00:07 PM

Wednesday, February 15, 2012 12:00:07 PM

Post# of 26138
I got a news release in my mail today at 11:42:


FOR IMMEDIATE RELEASE
BioSante Pharmaceuticals
NASDAQ: BPAX


BioSante Pharmaceuticals Announces FDA Approval for Bio-T-Gel™
LINCOLNSHIRE, Illinois (February 15, 2012) - BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced that the U.S. Food and Drug Administration (FDA) has approved Bio-T-Gel, which is licensed by BioSante to Teva Pharmaceuticals USA, Inc. Bio-T-Gel is a testosterone gel for the treatment of male hypogonadism or low testosterone levels. Male hypogonadism is generally characterized by impotence, a lack of sex drive, muscle weakness and osteoporosis.

Don't they send this to the press??
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up